Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Restructuring Costs (2022 - 2025)

Historic Restructuring Costs for Standard Biotools (LAB) over the last 5 years, with Q3 2025 value amounting to $9.4 million.

  • Standard Biotools' Restructuring Costs rose 8562.71% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year decrease of 4722.33%. This contributed to the annual value of $28.0 million for FY2024, which is 29407.04% up from last year.
  • Per Standard Biotools' latest filing, its Restructuring Costs stood at $9.4 million for Q3 2025, which was up 8562.71% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Restructuring Costs ranged from a high of $17.2 million in Q1 2024 and a low of $300000.0 during Q2 2022
  • Its 4-year average for Restructuring Costs is $4.2 million, with a median of $2.6 million in 2023.
  • Its Restructuring Costs has fluctuated over the past 5 years, first skyrocketed by 133025.0% in 2024, then crashed by 9095.73% in 2025.
  • Standard Biotools' Restructuring Costs (Quarter) stood at $4.6 million in 2022, then plummeted by 63.61% to $1.7 million in 2023, then surged by 75.37% to $3.0 million in 2024, then soared by 219.05% to $9.4 million in 2025.
  • Its Restructuring Costs stands at $9.4 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.6 million for Q1 2025.